Gilead Sciences, Inc. (ETR:GIS)

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.05B USD in the quarter ending June 30, 2025, with 2.05% growth. This brings the company's revenue in the last twelve months to $28.72B, up 3.96% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.61B with 6.22% growth.

• Revenue (ttm): $28.72B
• Revenue Growth: +3.96%
• P/S Ratio: 5.09
• Revenue / Employee: $1.63M
• Employees: 17,600
• Market Cap: 125.09B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.61B	1.68B	6.22%
Dec 31, 2023	26.93B	-48.00M	-0.18%
Dec 31, 2022	26.98B	-26.00M	-0.10%
Dec 31, 2021	27.01B	2.65B	10.89%
Dec 31, 2020	24.36B	2.24B	10.11%
Dec 31, 2019	22.12B	442.00M	2.04%
Dec 31, 2018	21.68B	-3.99B	-15.53%
Dec 31, 2017	25.66B	-4.29B	-14.33%
Dec 31, 2016	29.95B	-2.20B	-6.84%
Dec 31, 2015	32.15B	7.68B	31.37%
Dec 31, 2014	24.47B	13.67B	126.53%
Dec 31, 2013	10.80B	1.41B	14.96%
Dec 31, 2012	9.40B	1.01B	12.08%
Dec 31, 2011	8.39B	435.97M	5.48%
Dec 31, 2010	7.95B	938.04M	13.38%
Dec 31, 2009	7.01B	1.68B	31.40%
Dec 31, 2008	5.34B	1.11B	26.14%
Dec 31, 2007	4.23B	1.20B	39.78%
Dec 31, 2006	3.03B	997.74M	49.19%
Dec 31, 2005	2.03B	-	-